Breast Cancer Diagnostics Market is estimated to be US$ 9.10 billion by 2032 with a CAGR of 7.5% over the forecast period - By PMI
October 19, 2022 10:04 ET
|
PMI
Covina, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Breast Cancer Diagnostics Market accounted for US$ 4.5 billion in 2022 and is estimated to be US$ 9.10 billion by 2032 and is anticipated to register a CAGR...
Abrupt global expansion of the monkey pox virus has increased the demand for Monkey pox Disease Diagnostics Market - By PMI
August 25, 2022 08:53 ET
|
PMI
Covina, Aug. 25, 2022 (GLOBE NEWSWIRE) -- The virus that causes smallpox and the monkeypox both belong to the same family of viruses. Two outbreaks of a disease resembling the pox in groups of...
Global Lung Cancer Diagnostic Test Market is estimated to be US$ 4.07 billion by 2030 with a CAGR of 7.50% during the forecast period - By PMI
April 19, 2022 09:52 ET
|
PMI
Covina, April 19, 2022 (GLOBE NEWSWIRE) -- Lung cancer starts in the lungs and can spread to the lymph nodes or other body organs, including the brain. Cancer that has progressed to other organs can...
Global Sequencing Reagent Market is estimated to be US$ 14,190.4 million by 2027 with a CAGR of 13.8% during the forecast period - by PMI
July 20, 2021 10:05 ET
|
PMI
Covina, CA, July 20, 2021 (GLOBE NEWSWIRE) -- Sequencing reagents market garnered a revenue of USD 5,061.0 million in the year 2019 globally and has been foreseen to yield USD 14,190.4 million by...
Global Bioinformatics Platform Market is estimated to be US$ 14.0 Billion by 2029 with a CAGR of 14.7% during the Forecast Period - PMI
June 15, 2020 11:35 ET
|
PMI
Covina, CA, June 15, 2020 (GLOBE NEWSWIRE) -- The global bioinformatics platform market accounted for US$ 3.6 billion in 2019 and is estimated to be US$ 14.0 billion by 2029 and is anticipated to...
Bragar Eagel & Squire, P.C. Announces that it is Investigating the Boards of Directors of QIAGEN, The Meet Group, and Willis Tower Watson on behalf of Stockholders and Encourages Investors to Contact the Firm
March 09, 2020 20:09 ET
|
Bragar Eagel & Squire
NEW YORK, March 09, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. announces to investors that it is investigating potential claims on behalf of stockholders of QIAGEN N.V. (NYSE: QGEN),...
Bragar Eagel & Squire, P.C. Is Investigating HEXO, Pareteum, Qiagen, and Zendesk on Behalf of Stockholders and Encourages Investors to Contact the Firm
October 22, 2019 20:35 ET
|
Bragar Eagel & Squire
NEW YORK, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, is investigating potential claims against HEXO Corp. (NYSE: HEXO), Pareteum...
ViroGates and QIAGEN announces a partnership to launch suPARnostic® Quick Triage on QIAGEN’s automated Lateral Flow (aLF) platform
August 27, 2019 07:39 ET
|
ViroGates a/s
Company announcement 11-2019 Birkerød, Denmark and Hilden, Germany, 27 August 2019 ViroGates A/S (Nasdaq First North Denmark: VIRO), who delivers blood test systems, primarily for emergency...
Chinese-Based MedCDx and US-Based Admera Health Enter Into Strategic Partnership to Co-Develop Companion Diagnostics
February 26, 2019 09:21 ET
|
Admera Health, LLC
SOUTH PLAINFIELD, N.J., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Today, MedCDx and Admera Health announced a non-exclusive collaborative agreement. Under the terms of the agreement, MedCDx (formerly Qiagen...
Epigenetics Market To Rise With Need For Lasting Solutions To Health Issues - IndustryARC Research
March 22, 2017 14:30 ET
|
IndustryARC
Hyderabad, India, March 22, 2017 (GLOBE NEWSWIRE) -- The report “Epigenetics Market: By Products (Kits, Reagents, Enzymes, Others), By Application (Diagnostics, Drugs, Others), By End Users...